Pure Global

Rapamycin Coated Balloon Dilation Catheter for Arteriovenous Fistula - Trial NCT06029569

Access comprehensive clinical trial information for NCT06029569 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanghai Bomaian Medical Technology Co., Ltd and is currently Not yet recruiting. The study focuses on Peripheral Arterial Disease. Target enrollment is 256 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06029569
Not yet recruiting
procedure
Trial Details
ClinicalTrials.gov • NCT06029569
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Rapamycin Coated Balloon Dilation Catheter for Arteriovenous Fistula
Prospective, Multicenter, Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Rapamycin Coated Balloon Dilation Catheter in the Treatment of Dialysis Pathway Stenosis or Blockage in Hemodialysis Patients

Study Focus

Rapamycin drug balloon angioplasty

Interventional

procedure

Sponsor & Location

Shanghai Bomaian Medical Technology Co., Ltd

Timeline & Enrollment

N/A

Sep 15, 2023

Dec 15, 2025

256 participants

Primary Outcome

6-month target lesion primary patency rate

Summary

Verify the effectiveness and safety of rapamycin coated balloon dilation catheter for the
 treatment of dialysis pathway stenosis or blockage lesions.

ICD-10 Classifications

Peripheral vascular disease, unspecified
Other peripheral vascular diseases
Other specified peripheral vascular diseases
Peripheral angiopathy in diseases classified elsewhere
Other congenital malformations of peripheral vascular system

Data Source

ClinicalTrials.gov

NCT06029569

Non-Device Trial